Risk stratification of patients with barrett's esophagus and low-grade dysplasia or indefinite for dysplasia.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

In patients with Barrett's esophagus (BE), low-grade dysplasia (LGD) is a risk factor for esophageal adenocarcinoma (EAC), progressing at variable rates. Patients at higher risk for progression could benefit from intervention. We assessed rates of progression of LGD and indefinite for dysplasia (IND) and risk factors for progression to high-grade dysplasia (HGD) and EAC.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Clin. Gastroenterol. Hepatol.

Title: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Publisher: Elsevier BV

ISSN (Electronic): 1542-7714

ISSN (Print): 1542-3565

Publication date (Electronic): Mar 2015

Volume: 13

Issue: 3

Affiliations

[1 ] Center of Excellence for Barrett's Esophagus, Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio. Electronic address: thotap@ccf.org.

[2 ] Center of Excellence for Barrett's Esophagus, Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio.

[3 ] Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio.

[4 ] Department of Biostatistics, Cleveland Clinic, Cleveland, Ohio.

Article

Publisher Item ID: S1542-3565(14)01095-7

DOI: 10.1016/j.cgh.2014.07.049

PubMed ID: 25102445

SO-VID: 55f75f6f-70fc-4f85-b019-bc98f1e716cb

History

Keywords: Carcinogenesis,Esophageal Cancer,Patient Management,Tumor

Data availability:

Keywords: Carcinogenesis, Esophageal Cancer, Patient Management, Tumor

Comments

Comment on this article

scite_

Cited by 10

See all cited by

- Version 1